Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2031studies shown
Showing 193-204 of 2,031
Device study icon
RecruitingNCT07113665

Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Eating disorders With Comorbid OCD or Major Depressive Disorder

This study is looking at whether a digital support tool can help people with Eating disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In Toronto
Why is this study shown?

This study is directly about Depression.

Depression, Eating disorders, ...DeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
Canada
Sponsor
Sunnybrook Health Sciences Centre
Condition
Depression, Eating disorders, ...
Drug study icon
RecruitingNCT07002684

Metabolic Profiling of Esketamine Treatment in Depressive Disorder

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Zagreb
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
Croatia
Sponsor
University of Zagreb
Condition
Depression
Behavioral study icon
RecruitingNCT07159061

Neurofeedback to Treat Depression - 2

This study is comparing Active Closed Loop Real Time fMRI Neurofeedback with Sham Comparator: Sham Neurofeedback for people with depression. Participants receive Active Closed Loop Real Time fMRI Neurofeedback or Sham Comparator: Sham Neurofeedback and complete study visits and assessments.

In Philadelphia
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Depression
Drug study icon
RecruitingISRCTN77277298

Hypericum extract WS® 5570 for depression

This study is recruiting in Germany. It is testing Hypericum extract WS® 5570 for depression.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 18 Years
Countries
Germany
Sponsor
Schwabe Pharmaceuticals (Germany)
Condition
Depression
Behavioral study icon
RecruitingNCT06983405

Physical Therapy for Depression Quality of Life (Study Protocol)

This study is looking at whether a digital support tool can help people with depression. Participants take part in a digital support tool and complete follow-up assessments.

In Zaragoza
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
Spain
Sponsor
Universidad San Jorge
Condition
Depression
Device study icon
RecruitingNCT07294924

Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements

This observational study is following people with depression or Fnirs to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Los Angeles
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
Kernel
Condition
Depression
Drug study icon
RecruitingNCT06782724

Psilocybin Therapy for Psychological Distress in Palliative Patients

This study is looking at whether a digital support tool can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments.

Multiple locations, including Prague
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
Czechia, Denmark, Netherlands, ...
Sponsor
University Medical Center Groningen
Condition
Depression
Drug study icon
RecruitingNCT05922878

ALTO-300 in MDD

This study is looking at determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Depression
Behavioral study icon
RecruitingNCT07076342

The Role of mGluR5 in CBT-I

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Stony Brook
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
Stony Brook University
Condition
Depression
Biological study icon
RecruitingNCT05585047

Treatment Response Biomarkers in MDD

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Changsha
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 60 Years
Countries
China
Sponsor
Zhang Yan
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.